Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002 Dec 18; 288(23):2981-97.

View in: PubMed

subject areas

Aged
Amlodipine
Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Agents
Calcium Channel Blockers
Cardiovascular Diseases
Chlorthalidone
Diuretics
Double-Blind Method
Female
Humans
Hypertension
Lisinopril
Male
Middle Aged
Proportional Hazards Models
Risk Factors
Treatment Outcome

authors with profiles

Jeff D. Williamson MD, MHS